Product Description: Lokivetmab (Anti-Canine IL31 Recombinant Antibody) is an anti-canine IL-31 monoclonal antibody that can be used for the research of atopic dermatitis (AD) in dogs[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Meichner K, et al. Lokivetmab therapy for pruritus in a dog with cutaneous mastocytosis. Vet Dermatol. 2019 Feb;30(1):73-e22.